Walgreens Boots Alliance Inc (WBA) Shares Sold by Guidant Wealth Advisors
Guidant Wealth Advisors trimmed its position in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 19.1% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 14,456 shares of the pharmacy operator’s stock after selling 3,406 shares during the quarter. Walgreens Boots Alliance makes up approximately 0.7% of Guidant Wealth Advisors’ investment portfolio, making the stock its 23rd largest position. Guidant Wealth Advisors’ holdings in Walgreens Boots Alliance were worth $1,024,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently modified their holdings of WBA. Schroder Investment Management Group increased its position in shares of Walgreens Boots Alliance by 17.1% during the first quarter. Schroder Investment Management Group now owns 2,588,887 shares of the pharmacy operator’s stock worth $215,681,000 after purchasing an additional 378,686 shares in the last quarter. Bank of Hawaii grew its holdings in Walgreens Boots Alliance by 16.3% in the 1st quarter. Bank of Hawaii now owns 7,589 shares of the pharmacy operator’s stock valued at $631,000 after buying an additional 1,063 shares in the last quarter. American International Group Inc. grew its holdings in Walgreens Boots Alliance by 1.9% in the 1st quarter. American International Group Inc. now owns 441,183 shares of the pharmacy operator’s stock valued at $36,640,000 after buying an additional 8,322 shares in the last quarter. Concert Wealth Management Inc. purchased a new stake in Walgreens Boots Alliance in the 1st quarter valued at $261,000. Finally, Cibc World Markets Corp grew its holdings in Walgreens Boots Alliance by 8.8% in the 1st quarter. Cibc World Markets Corp now owns 374,075 shares of the pharmacy operator’s stock valued at $31,067,000 after buying an additional 30,341 shares in the last quarter. Hedge funds and other institutional investors own 61.41% of the company’s stock.
In related news, Director William C. Foote sold 2,736 shares of the stock in a transaction dated Thursday, November 2nd. The stock was sold at an average price of $67.37, for a total transaction of $184,324.32. Following the transaction, the director now owns 16,415 shares of the company’s stock, valued at approximately $1,105,878.55. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director John Anthony Lederer bought 20,000 shares of the firm’s stock in a transaction that occurred on Thursday, October 26th. The shares were purchased at an average cost of $67.00 per share, for a total transaction of $1,340,000.00. Following the purchase, the director now owns 50,000 shares in the company, valued at approximately $3,350,000. The disclosure for this purchase can be found here. 14.80% of the stock is currently owned by corporate insiders.
Walgreens Boots Alliance Inc (NASDAQ WBA) opened at $71.55 on Monday. Walgreens Boots Alliance Inc has a 12 month low of $63.82 and a 12 month high of $88.00. The company has a current ratio of 1.07, a quick ratio of 0.59 and a debt-to-equity ratio of 0.45. The stock has a market capitalization of $70,859.95, a PE ratio of 14.03, a P/E/G ratio of 1.28 and a beta of 1.22.
Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Wednesday, October 25th. The pharmacy operator reported $1.31 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.21 by $0.10. Walgreens Boots Alliance had a return on equity of 18.36% and a net margin of 3.45%. The firm had revenue of $30.15 billion for the quarter, compared to analyst estimates of $29.93 billion. During the same quarter in the prior year, the company earned $1.07 EPS. Walgreens Boots Alliance’s revenue was up 5.3% on a year-over-year basis. analysts forecast that Walgreens Boots Alliance Inc will post 5.54 earnings per share for the current year.
Walgreens Boots Alliance declared that its board has initiated a stock buyback program on Wednesday, October 25th that permits the company to buyback $1.00 billion in outstanding shares. This buyback authorization permits the pharmacy operator to reacquire shares of its stock through open market purchases. Shares buyback programs are generally an indication that the company’s management believes its shares are undervalued.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 12th. Investors of record on Monday, November 13th will be paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 2.24%. The ex-dividend date is Friday, November 10th. Walgreens Boots Alliance’s payout ratio is 42.33%.
Several analysts have issued reports on the company. UBS restated a “buy” rating and issued a $96.00 target price (down from $97.00) on shares of Walgreens Boots Alliance in a report on Wednesday, August 23rd. Royal Bank Of Canada assumed coverage on Walgreens Boots Alliance in a report on Tuesday, September 19th. They issued an “outperform” rating and a $96.00 target price for the company. Jefferies Group restated a “buy” rating and issued a $95.00 target price on shares of Walgreens Boots Alliance in a report on Monday, October 2nd. Deutsche Bank began coverage on Walgreens Boots Alliance in a report on Monday, December 4th. They issued a “hold” rating and a $78.00 target price for the company. Finally, Raymond James Financial reiterated a “market perform” rating on shares of Walgreens Boots Alliance in a report on Wednesday, September 27th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and fourteen have given a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus target price of $86.47.
COPYRIGHT VIOLATION NOTICE: This report was first posted by Watch List News and is the property of of Watch List News. If you are accessing this report on another publication, it was copied illegally and reposted in violation of U.S. & international copyright and trademark laws. The legal version of this report can be read at https://www.watchlistnews.com/walgreens-boots-alliance-inc-wba-shares-sold-by-guidant-wealth-advisors/1757155.html.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.